Axsome Therapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AXSM and other ETFs, options, and stocks.

About AXSM

Axsome Therapeutics, Inc. engages in the development of novel therapies for the management of central nervous system disorders. Its product candidates include AXS-05, AXS-07, AXS-12, and AXS-14 which are being developed for multiple pain and primary care indications.

CEO

Herriott Tabuteau

CEOHerriott Tabuteau

Employees

108

Employees108

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2012

Founded2012

Employees

108

Employees108

AXSM Key Statistics

Market cap

2.03B

Market cap2.03B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

1.21M

Average volume1.21M

High today

$51.89

High today$51.89

Low today

$48.69

Low today$48.69

Open price

$51.80

Open price$51.80

Volume

1.31M

Volume1.31M

52 Week high

$71.98

52 Week high$71.98

52 Week low

$20.63

52 Week low$20.63

Analyst ratings

86%

of 14 ratings

Buy

85.7%

Hold

7.1%

Sell

7.1%

AXSM Earnings

-$1.24

-$0.83

-$0.41

$0.00

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 7, Pre-Market

ActualExpected Nov 7, Pre-Market